
Noble E. Jarrell
Examiner (ID: 19030)
| Most Active Art Unit | 1699 |
| Art Unit(s) | 1625, 1699, 1609, 1624, 1622, 1629 |
| Total Applications | 1452 |
| Issued Applications | 961 |
| Pending Applications | 170 |
| Abandoned Applications | 340 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17303389
[patent_doc_number] => 20210399228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => COMPOUND, PRODUCTION METHOD THEREFOR, AND ORGANIC SEMICONDUCTOR MATERIAL OBTAINED USING SAID COMPOUND
[patent_app_type] => utility
[patent_app_number] => 17/288949
[patent_app_country] => US
[patent_app_date] => 2019-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24019
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 371
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17288949
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/288949 | Compound, production method therefor, and organic semiconductor material obtained using said compound | Oct 24, 2019 | Issued |
Array
(
[id] => 15797327
[patent_doc_number] => 20200121806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-23
[patent_title] => MAYTANSINOID DERIVATIVES, CONJUGATES THEREOF, AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/663251
[patent_app_country] => US
[patent_app_date] => 2019-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33380
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16663251
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/663251 | Maytansinoid derivatives, conjugates thereof, and methods of use | Oct 23, 2019 | Issued |
Array
(
[id] => 16973880
[patent_doc_number] => 11069863
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-20
[patent_title] => Organic thin film and organic thin film transistor and electronic device
[patent_app_type] => utility
[patent_app_number] => 16/661631
[patent_app_country] => US
[patent_app_date] => 2019-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 13085
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 282
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16661631
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/661631 | Organic thin film and organic thin film transistor and electronic device | Oct 22, 2019 | Issued |
Array
(
[id] => 15496153
[patent_doc_number] => 20200048265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => HETEROCYCLIC COMPOUNDS AND THEIR USES
[patent_app_type] => utility
[patent_app_number] => 16/656328
[patent_app_country] => US
[patent_app_date] => 2019-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54462
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16656328
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/656328 | HETEROCYCLIC COMPOUNDS AND THEIR USES | Oct 16, 2019 | Abandoned |
Array
(
[id] => 15454331
[patent_doc_number] => 20200039990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-06
[patent_title] => SHORT-ACTING BENZODIAZEPINE SALTS AND THEIR POLYMORPHIC FORMS
[patent_app_type] => utility
[patent_app_number] => 16/598876
[patent_app_country] => US
[patent_app_date] => 2019-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16479
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16598876
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/598876 | Short-acting benzodiazepine salts and their polymorphic forms | Oct 9, 2019 | Issued |
Array
(
[id] => 18124015
[patent_doc_number] => 20230009626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-12
[patent_title] => INDOLINONE COMPOUNDS FOR USE AS MAP4K1 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/282432
[patent_app_country] => US
[patent_app_date] => 2019-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40125
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17282432
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/282432 | INDOLINONE COMPOUNDS FOR USE AS MAP4K1 INHIBITORS | Oct 6, 2019 | Abandoned |
Array
(
[id] => 15681131
[patent_doc_number] => 20200095229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-26
[patent_title] => Purified cenicriviroc and purified intermediates for making cenicriviroc
[patent_app_type] => utility
[patent_app_number] => 16/561969
[patent_app_country] => US
[patent_app_date] => 2019-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19963
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16561969
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/561969 | Purified cenicriviroc and purified intermediates for making cenicriviroc | Sep 4, 2019 | Abandoned |
Array
(
[id] => 15813885
[patent_doc_number] => 10632099
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-28
[patent_title] => Non-aromatic difluoro analogues of resorcylic acid lactones
[patent_app_type] => utility
[patent_app_number] => 16/556626
[patent_app_country] => US
[patent_app_date] => 2019-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 18297
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 479
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16556626
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/556626 | Non-aromatic difluoro analogues of resorcylic acid lactones | Aug 29, 2019 | Issued |
Array
(
[id] => 15363415
[patent_doc_number] => 20200017472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => N-SUBSTITUTED SULFONAMIDE COMPOUND AND METHOD FOR PRODUCING SAME
[patent_app_type] => utility
[patent_app_number] => 16/556978
[patent_app_country] => US
[patent_app_date] => 2019-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12386
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16556978
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/556978 | Crystal of N-substituted sulfonamide compound | Aug 29, 2019 | Issued |
Array
(
[id] => 16519452
[patent_doc_number] => 10870662
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-22
[patent_title] => Alpha-amino pateamine A derivatives and methods for treating chronic lymphocytic leukemia
[patent_app_type] => utility
[patent_app_number] => 16/555741
[patent_app_country] => US
[patent_app_date] => 2019-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 14619
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16555741
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/555741 | Alpha-amino pateamine A derivatives and methods for treating chronic lymphocytic leukemia | Aug 28, 2019 | Issued |
Array
(
[id] => 15586223
[patent_doc_number] => 20200069646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
[patent_app_type] => utility
[patent_app_number] => 16/555634
[patent_app_country] => US
[patent_app_date] => 2019-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33173
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 162
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16555634
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/555634 | Inhibitors of indoleamine 2,3-dioxygenase and methods of their use | Aug 28, 2019 | Issued |
Array
(
[id] => 19372873
[patent_doc_number] => 12064412
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-20
[patent_title] => Method for preparing solution formulation for aerosol inhalation of naringenin
[patent_app_type] => utility
[patent_app_number] => 16/976728
[patent_app_country] => US
[patent_app_date] => 2019-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3447
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16976728
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/976728 | Method for preparing solution formulation for aerosol inhalation of naringenin | Aug 27, 2019 | Issued |
Array
(
[id] => 16696618
[patent_doc_number] => 10947198
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-16
[patent_title] => Chroman-substituted, tetrahydroquinoline-substituted and thiochroman-substituted heteroarotinoids as anti-cancer agents
[patent_app_type] => utility
[patent_app_number] => 16/549337
[patent_app_country] => US
[patent_app_date] => 2019-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26558
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16549337
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/549337 | Chroman-substituted, tetrahydroquinoline-substituted and thiochroman-substituted heteroarotinoids as anti-cancer agents | Aug 22, 2019 | Issued |
Array
(
[id] => 15556633
[patent_doc_number] => 20200062728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => QUINOLINE-BASED COMPOUNDS AND METHODS OF INHIBITING CDK8/19
[patent_app_type] => utility
[patent_app_number] => 16/547350
[patent_app_country] => US
[patent_app_date] => 2019-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15872
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16547350
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/547350 | Quinoline-based compounds and methods of inhibiting CDK8/19 | Aug 20, 2019 | Issued |
Array
(
[id] => 16841637
[patent_doc_number] => 11013696
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-25
[patent_title] => Lipids and lipid compositions for the delivery of active agents
[patent_app_type] => utility
[patent_app_number] => 16/537934
[patent_app_country] => US
[patent_app_date] => 2019-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 60263
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16537934
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/537934 | Lipids and lipid compositions for the delivery of active agents | Aug 11, 2019 | Issued |
Array
(
[id] => 19922911
[patent_doc_number] => 12297181
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-13
[patent_title] => Methods to chemically modify cannabinoids
[patent_app_type] => utility
[patent_app_number] => 17/267279
[patent_app_country] => US
[patent_app_date] => 2019-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 6092
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17267279
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/267279 | Methods to chemically modify cannabinoids | Aug 8, 2019 | Issued |
Array
(
[id] => 16896553
[patent_doc_number] => 11038116
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-15
[patent_title] => Compound and organic thin film and thin film transistor and electronic device
[patent_app_type] => utility
[patent_app_number] => 16/531376
[patent_app_country] => US
[patent_app_date] => 2019-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12523
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 244
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16531376
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/531376 | Compound and organic thin film and thin film transistor and electronic device | Aug 4, 2019 | Issued |
Array
(
[id] => 17183757
[patent_doc_number] => 20210330642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => METHOD FOR TREATING CANCER BY COMBINATION OF IAP INHIBITOR AND MODULATOR OF IMMUNE CHECKPOINT MOLECULE
[patent_app_type] => utility
[patent_app_number] => 16/618792
[patent_app_country] => US
[patent_app_date] => 2019-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18963
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16618792
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/618792 | Method for treating cancer by combination of IAP inhibitor and modulator of immune checkpoint molecule | Jul 29, 2019 | Issued |
Array
(
[id] => 15035399
[patent_doc_number] => 20190328704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => SUPER-OXIDE DISMUTASE MIMETICS
[patent_app_type] => utility
[patent_app_number] => 16/509131
[patent_app_country] => US
[patent_app_date] => 2019-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9105
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16509131
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/509131 | SUPER-OXIDE DISMUTASE MIMETICS | Jul 10, 2019 | Abandoned |
Array
(
[id] => 17784631
[patent_doc_number] => 11407743
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-09
[patent_title] => Amphiphilic and mesogenic organic dyes for tailor-made reflective low-dimensional materials
[patent_app_type] => utility
[patent_app_number] => 17/257031
[patent_app_country] => US
[patent_app_date] => 2019-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 26
[patent_no_of_words] => 18015
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 690
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17257031
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/257031 | Amphiphilic and mesogenic organic dyes for tailor-made reflective low-dimensional materials | Jul 4, 2019 | Issued |